期刊文献+

冠状动脉粥样硬化性心脏病介入术后发生造影剂肾病的相关因素分析 被引量:7

Correlation factors of contrast-induced nephropathy after coronary artery intervention among patients with coronary atherosclerotic heart disease
下载PDF
导出
摘要 目的分析冠状动脉粥样硬化性心脏病患者行冠状动脉介入操作后发生造影剂肾病(CIN)的危险因素及相关性。方法 650例冠状动脉粥样硬化性心脏病患者使用造影剂威视派克行介入操作,分析入选病例的基础资料、CIN的发病率,分组讨论CIN发生的相关危险因素。结果 650例冠状动脉粥样硬化性心脏病患者行冠脉介入后有56例发生CIN(发病率为8.6%),使用较高剂量造影剂(≥95 mL)、左心收缩功能不全、2型糖尿病、高龄、eGFR<60 mL/(min.1.73m2)、诊断为急性冠脉综合征、合并高血压、存在冠脉病变的患者CIN发病率较高(P<0.05)。Logistic回归分析显示eGFR<60 mL/(min.1.73m2)(RR=6.50,P=0.003)、诊断急性冠脉综合征(RR=2.67,P=0.049)、高血压(RR=5.11,P=0.036)是CIN发病的危险因素。结论造影剂剂量较大、左心收缩功能不全、2型糖尿病、高龄、eGFR<60 mL/(min.1.73m2)、诊断急性冠脉综合征、高血压、存在冠脉病变等高危因素的患者CIN发病率高,eGFR<60 mL/(min.1.73m2)、诊断急性冠脉综合征、高血压可能是CIN发生的危险因素。 Objective To analyze the correlation factors of contrast-induced nephropathy(CIN) in coronary atheroscle rotic heart disease patients underwent coronary artery intervention.Methods 650 patients were admitted the Department of Cardiology of the First Affiliated Hospital of Xinxiang Medical College and treated with coronary artery inter vention,basic data were collected respectively,and overall incidence of CIN and risk factors of CIN were analyzed.Results Of the 650 patients,56 cases suffered with CIN(the incidence was 8.6%).The CIN incidences in patients of contrast media volume ≥95 mL,left ventricular systolic dysfunction,type 2 diabetes,aged patients,eGFR &lt;60 mL/(min.1.73m2),diagnosis of acute coronary syndrome,and patients with hypertension,multiple vessel disease were higher(P &lt; 0.05).Multivariate Logistic regression analysis indicated that eGFR&lt;60 mL/(min.1.73m2)(RR = 6.50,P = 0.003),diagnosis of Acute Coronary Syndrome(RR = 2.67,P = 0.049),hypertension(RR = 5.11,P = 0.036) were the risk factors for CIN.Conclusion Larger dose of contrast agent,left ventricular systolic dysfunction,type 2 diabetes,advanced age,eGFR &lt;60 mL/(min.1.73m2),diagnosis of acute coronary syndrome,hypertension,the presence of coronary lesions and other risk factors in patients have a high incidence of CIN.eGFR &lt;60 mL/(min.1.73m2),diagnosis of acute coronary syndrome,hypertension may be risk factors for CIN occurred.
出处 《中国医药导报》 CAS 2013年第17期34-36,39,共4页 China Medical Herald
基金 河南省高等教育青年骨干教师计划资助项目(编号2009GGJS-085)
关键词 经皮冠状动脉介入 冠状动脉造影 造影剂肾病 发病率 Percutaneous coronary intervention Coronary angiography Dontrast-induced nephropathy Incidence
  • 相关文献

参考文献12

  • 1Zuo L, Ma YC,Zhou YH,et al. Application of GFR-estimating equa- tions in Chinese patients with chronic kidney disease [J]. American journal of kidney diseases :the official journal of the National Kidney Foundation, 2005,45 (3) : 463.
  • 2Stacul F,van der Molen AJ,Reimer P,et al. Contrast induced nephropathy:updated ESUR contrast media safety Committee guide- lines [J]. European radidi0gy,20H,21 (12):2527-2541.
  • 3Iakovou 1,Dangas G, Mehran R,et al. Impact of gender on the inci- dence and outcome of contrast-induced nephropathy after percuta- neous coronary intervention [J]. The Journal of invasive cardiology, 2003,15(1) :18.
  • 4Calabrb P,Bianchi R,Crisci M,et al. Use and efficacy of saline hy- dration and N-acetyl cysteine to prevent contrast-induced nephropa- thy in low-risk populations undergoing coronary artery angiography []].Internal and Emergency Medicine, 2011,6 (6) : 503-507.
  • 5赵瑛瑛,刘东伟,王建生,欧阳军,张宛哲,张文吉,孟晶茜,汤建民.冠状动脉介入诊疗并发造影剂肾病的危险因素[J].中华医学杂志,2012,92(22):1547-1549. 被引量:29
  • 6郑志伟,陈翠仪,康彦红,钟诗龙,杨敏,劳海燕.冠状动脉介入治疗后造影剂肾病的危险因素研究[J].岭南心血管病杂志,2012,18(1):17-19. 被引量:19
  • 7陈侃,钱菊英,葛雷,刘学波,樊冰,王齐兵,张峰,黄东,马剑英,葛均波.冠状动脉介入诊疗术对肾功能影响的532例分析[J].中国介入心脏病学杂志,2009,17(3):153-156. 被引量:14
  • 8Cruz DN, Goh CY, Marenzi G,et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy:a systematic review [J]. The American journal of medicine, 2012,125(1 ) :66-78.
  • 9Zhang BC,Li WM,Xu YW. High-dose statin pretreatment for the prevention of contrast-induced nephropathy:a meta-analysis [J]. Canadian Journal of Cardiology ,2011,27(6) :851-858.
  • 10Ozhan H, Erden I, Ordu S, et al. Efficacy of short-term high-dose a- torvastatin for prevention of contrast-induced nephropathy in pa- tients undergoing coronary angiography [J]. Angiology,2010,61 (7): 711-714.

二级参考文献33

  • 1来莺,陈万春,赵德强,金惠根.冠状动脉造影对肾功能影响1087例分析[J].岭南心血管病杂志,2006,12(6):398-400. 被引量:4
  • 2吉俊,丁小强,许迅辉,邹建洲,何建强,林贻梅,柏瑾,钱菊英.低渗非离子造影剂对冠状动脉介入诊疗术患者肾功能影响的前瞻性研究[J].中华肾脏病杂志,2006,22(7):388-392. 被引量:46
  • 3丁尧海,陈海英,张爱平.造影剂肾病的危险因素和预防[J].中国误诊学杂志,2006,6(16):3087-3088. 被引量:15
  • 4Berns AS.Nephrotoxicity of contrast media.Kidney Int,1989,36:730-740.
  • 5McCullough PA,Wolyn R,Rocher LL,et al.Acute renal failure after coronary intervention:Incidence,risk factors,and relationship to mortality.Am J Med,1997,103:368-375.
  • 6Toprak O.Risk Markers for Contrast-Induced Nephropathy.Am J Med Sci,2007,334:283-290.
  • 7Thomsen HS,Morcos SK.Contrast media and the kidney:European Society of Urogenital Radiololgy (ESUR) guidelines.Br J Radiol,2003,76:513-518.
  • 8Rich MW,Crecelius CA.Incidence,risk factors,and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older.A prospective study.Arch Intern Med,1990,150:1237-1242.
  • 9Barrett BJ,Carlisle EJ.Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media.Radiology,1993,188:171-178.
  • 10Aspelin P,Aubry P,Fransson S,et al.Nephrotoxic effects in high-risk patients undergoing angiography.N EnglJ Med,2003,348:491-499.

共引文献51

同被引文献98

  • 1姜文兵,傅国胜.造影剂肾病预防的研究进展[J].临床荟萃,2006,21(12):897-900. 被引量:23
  • 2苏海华.造影剂肾病的诊疗进展[J].国际移植及血液净化杂志,2006,4(3):1-4.
  • 3Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy : A literature review[J]. J Nephropathol, 2014,3 (2) 51-56.
  • 4Tehrani S, Laing C, Yellon DM, et al. Contrast-induced acute kidney injury following PCI[J]. Eur J Clin Invest, 2013,43 (5) :483-490.
  • 5Patti G, Ricottini E, Nusca A, et al. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy trial[J]. Am J Cardiol,2011,108(1) : 1-7.
  • 6陈涛,张杰.胱抑素C在心血管病学中的研究进展[J].中华临床医师杂志:电子版,2013,7(10):4481-4484.
  • 7Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insuficiencyin patients undergoing primary angioplasty for acute myocardialinfarction[J]. Circulation, 2003,108(22): 2769-2775.
  • 8Sudarsky D, Nikolsky E. Contrast-induced nephropathy ininterventional cardiology [J]. Int J Nephrol Renovasc Dis, 2011, 7(4):85-99.
  • 9Marenzi G, De Metrio M, Rubino M, et al. Acute hyperglycemia andcontrast-induced nephropathy in primary percutaneous coronaryintery^ntion[J]. Am Heart J,2010, 160(6): 1170-1177.
  • 10Verzola D, Bertolotto MB, Villaqqio B, et al. Taurine preventsapoptosis induced by high ambient glucose in human tubule renalcells[J]. J Investig Med, 2002, 50(6): 443-451.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部